Wei L - Search Results

1

Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Omata M, Kanda T, Yokosuka O, Crawford D, Al-Mahtab M, Wei L, Ibrahim A, Lau GK, Sharma BC, Hamid SS, Chuang WL, Dokmeci AK. Omata M, et al. Among authors: wei l. Hepatol Int. 2015 Oct;9(4):486-507. doi: 10.1007/s12072-015-9630-4. Epub 2015 May 5. Hepatol Int. 2015. PMID: 25941137 Review.

2

[Relationship between the genotypes of hepatitis B virus and the severity of liver diseases].

Xu J, Wang QX, Jiang D, Yang LM, Zhao YL, Chen HS, Wei L. Xu J, et al. Among authors: wei l. Zhonghua Gan Zang Bing Za Zhi. 2003 Jan;11(1):11-3. Zhonghua Gan Zang Bing Za Zhi. 2003. PMID: 12546732 Chinese.

3

[Using RNA interference to treat hepatitis virus: hope for future development].

Wei L. Wei L. Zhonghua Gan Zang Bing Za Zhi. 2004 Sep;12(9):555. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15387911 Chinese. No abstract available.

4

[YVDD is the primary symbol of gene mutation in hepatitis B patients treated with lamivudine].

Tian Y, Du SC, Zhang R, Wei L, Chen Y, Han JD. Tian Y, et al. Among authors: wei l. Zhonghua Gan Zang Bing Za Zhi. 2005 Jun;13(6):455-6. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15975283 Chinese. No abstract available.

5

[Dynamic variations of hepatitis B virus polymerase gene in lamivudine-treated hepatitis B patients].

Feng B, Wei L, Chen M, Han FZ, Wang LP. Feng B, et al. Among authors: wei l. Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):327-30. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16732904 Chinese.

6

[Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection].

Wei L. Wei L. Zhonghua Gan Zang Bing Za Zhi. 2006 Nov;14(11):836-7. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 17125613 Chinese. No abstract available.

7

Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.

Jia Y, Wei L, Jiang D, Wang J, Cong X, Fei R. Jia Y, et al. Among authors: wei l. J Gastroenterol Hepatol. 2007 Aug;22(8):1278-85. doi: 10.1111/j.1440-1746.2007.04957.x. Epub 2007 Jun 12. J Gastroenterol Hepatol. 2007. PMID: 17565587

8

Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis.

Ma H, Wei L, Guo F, Zhu S, Sun Y, Wang H. Ma H, et al. Among authors: wei l. J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1250-8. doi: 10.1111/j.1440-1746.2008.05499.x. Epub 2008 Jul 8. J Gastroenterol Hepatol. 2008. PMID: 18624896

9

[Stem cells therapy and severe acute exacerbation of chronic hepatitis B].

Liu F, Chen HS, Wei L. Liu F, et al. Among authors: wei l. Zhonghua Gan Zang Bing Za Zhi. 2010 Apr;18(4):256-8. doi: 10.3760/cma.j.issn.1007-3418.2010.04.005. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20460042 Chinese. No abstract available.

10

Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients.

Ma H, Yang RF, Wei L. Ma H, et al. Among authors: wei l. J Gastroenterol Hepatol. 2010 Sep;25(9):1498-506. doi: 10.1111/j.1440-1746.2010.06282.x. J Gastroenterol Hepatol. 2010. PMID: 20796146 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,104 results

Search Page

Filters